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orientation – in addition to the portrait-landscape 
dependence – when scanning the film. However, these 
dependences are manageable by a consistent film handling 
and scanning procedure, using the small slit marker provided 
by the manufacturer near a corner of each film. Instead, we 
explored whether combining a film and an upside down 
flipped one during exposure, hence creating a difference of 
100-μm polyester build-up, allows differentiating the dose 
within the steep superficial dose buildup, typical for photon 
beams. Our study was further motivated by the fact that the 
depth of the basal layer, containing the dividing cells in the 
human skin and being related to radiation-induced skin 
toxicity, varies from 40 to 100 μm (ICRP 59).  
Materials and Methods: First, a 6-MV 10x10-cm2 beam was 
investigated at 100-cm SSD and for 400 MU. Film pieces of 
1x3-cm2, marked for orientation, were put on top of a flat 
polystyrene phantom. Films were irradiated in pairs by 
flipping them upside down. All films were scanned (Epson 
Expression 1680) with the substrate layer down. Effects of 
field size, oblique incidence and increasing the photon 
energy to 18 MV were examined as well. Finally, a clinical 6-
MV 3-segment IMRT beam, belonging to a treatment plan for 
a mediastinal tumour, was investigated. 
Results: The 6-MV beam deposited doses of 82.6 cGy and 
99.9 cGy at water depths of 115 μm (substrate down) and 254 
μm (substrate up) respectively. The statistically significant 
dose difference of 17.3 cGy over 100 μm polyester reveals a 
dose gradient of 3.2 %/(100 μm water) relative to the dose at 
5-cm water depth. The gradient reached 3.7 % in a position 
offset to the beam axis and increased further for smaller 
field sizes. An oblique incidence of 45° resulted in a gradient 
of 4.0 %. The 18-MV beam resulted in a dose gradient of 1.5 
%/(100 μm water) relative to the dose at 10-cm water depth.  
The film-measured surface doses for the clinical IMRT beam 
(Fig. a and b) follows the same lines. The dose difference 
map (Fig. c) further demonstrates that the surface gradient 




Conclusions: The dose gradients measured at the surface are 
very steep in the 6-MV fields and their values are slightly but 
significantly higher than what we found in literature, 
presumably by virtue of the shallow reproducible 
measurement depths provided by EBT2 film.  
We developed a robust and versatile method to precisely 
assess the surface dose in pretreatment conditions. The 
extension to in-vivo dosimetry is straightforward and will 
guide us to manage skin toxicity in stereotactic body 
radiotherapy or setups with beam passage through the couch 
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Purpose/Objective: The aim of this study is to assess the 
clinical feasibility of a measurement-based 2D EPID transit 
dosimetry model that can predict either: (1) in-vivo dose or 
(2) EPID transit dose, for actual treatment verification. 
Materials and Methods: The model was based on a quadratic 
equation that relates the reduction in intensity (given as the 
ratio of exit to entrance dose planes) with equivalent path 
length (EPL) of the attenuator. Two sets of quadratic 
equation coefficients were derived so that EPL can be 
calculated from either EPID or TPS entrance and exit dose 
planes. Consequently, either the in-vivo exit dose or the EPID 
transit dose can be predicted from the EPL. In addition to in-
vivo exit dose, doses at other planes (for example, isocentre) 
can also be predicted using information from patients' CT 
images and a 'CT number to EPL' calibration curve. The model 
was first tested on an anthropomorphic phantom using 65 
test fields (open, 3D conformal, wedge, and IMRT fields) with 
variable gantry angles. Finally, the model was used to verify 
the accuracy of patients' actual treatment. A total of 18 
fields were captured with EPID during patients' treatment and 
evaluated. Comparisons were done using 2D absolute global 
gamma analysis. 
Results: For the 65 fields tested on anthropomorphic 
phantom, the average gamma pass rates, using a 4%/4mm 
criterion, were 98.9%±1.20% (range: 95.7%-100%) and 
98.8%±1.35% (range: 95.2%-100%) for in-vivo comparisons at 
the exit and isocentre planes respectively. The average 
gamma pass rate was 98.0%±1.73% (range: 93.8%-100%) for 
direct comparisons at the EPID level. 
For the evaluation of patients' treatment fields, the average 
gamma pass rates, using a 5%/5mm criterion, were 
97.0%±1.90% (range: 92.4%-99.6%) and 98.6%±1.40% (range: 
96.1%-100%) for in-vivo comparisons at the exit and isocentre 
planes respectively. The average gamma pass rate was 
95.6%±2.30% (range: 90.7%-99.9%) for direct comparisons at 
the EPID level. 
Conclusions: A novel 2D EPID transit dosimetry model that 
can predict in-vivo doses at multiple planes as well as EPID 
transit dose has been shown to be clinically feasible. The 
model provides an additional safety net to ensure that 
patients' radiation treatments are accurately delivered as 
planned.  
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Purpose/Objective: Collaborative Ocular Melanoma Study 
(COMS) eye plaques contain silastic and Modulay materials 
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that introduce 15%-30% dose differences compared with all-
water dosimetry. A TG43 dose rate calculation method is 
presented that includes silastic and Modulay heterogeneous 
effects, uses the actual plaque seed configuration, is not 
restricted to a particular commercial treatment planning 
system, and does not require purchase of additional 
software.  
Materials and Methods: Dose rate is calculated using TG43 
formalism: DoseEP(r, θ)= SkΛ[GL(r,θ)/GL(r0,θ0)]gEP(r)FEP(r,θ), 
with revised radial dose, gEP(r), and anisotropy, FEP(r,θ), 
functions specific to I-125 or Pd-103 seeds in COMS eye 
plaques. EP signifies that the functions are specific to COMS 
eye plaques. gEP(r), is obtained from Monte Carlo data for eye 
plaques that contain just a single center seed. FEP(r,θ) is 
obtained by performing a Nelder-Mead Simplex routine to 
find a least squares solution that minimizes differences 
between Monte Carlo dose rate and DoseEP(r, θ). 
Figure: EP method calculation accuracy over the inner sclera 
surface for 10 mm and 22 mm COMS eye plaques. Dose rate 
for each curve is normalized to the value at central axis. 
 
 
Results: TG43 formalism calculations agree with Monte Carlo 
results, for 10 mm though 22 mm I-125 and Pd-103 eye 
plaques, to within 2% along and near the plaque central axis 
and within 4% in the penumbra region for depths ≥ 1 mm. 
Methods and data for calculating dose rate for COMS plaques 
with seed model other than I-125 Model 6711 and Pd-103 
Model 200 are provided. Since actual seed configurations are 
used in dose rate calculations, this formalism may also be 
used to estimate dosimetry for non-standard seed loadings. 
Conclusions: This manuscript enables the clinical user to 
perform accurate heterogeneity-corrected dose rate 
calculations for COMS eye plaques using TG43 formalism in a 
spreadsheet or commercial treatment planning system that 
has a TG43 line source geometry function calculation 
capabilities.  
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Purpose/Objective: The quality of radiotherapy treatment 
can be increased by visualising the tumour volume during 
irradiation. This is achieved by means of an MRI-Linac, which 
combines patient irradiation and real-time treatment 
guidance with excellent soft-tissue contrast. Within an EMRP 
Joint Research Project [1], we are currently investigating 
whether interaction cross sections used in Monte Carlo codes 
for the simulation of low-energy secondary electron transport 
require modification owing to the presence of a magnetic 
field. For this purpose, the calculated differential cross 
sections (DCS) for electron scattering with and without 
magnetic field were compared. 
Materials and Methods: Since water molecules are 
diamagnetic, they can be expected to partially orient 
themselves under the influence of an external magnetic 
field. This is because the overall energy of the water 
molecules depends on the relative orientation of the 
molecule with respect to the magnetic field. The orientation 
of a single water molecule was defined using the Euler angles 
(α,β,γ), which describe a sequence of rotations around two 
perpendicular axes. A data set of DCS for elastic scattering 
and ionisation was computed for various values of the Euler 
angles from 0° to 360° and incident energies varying between 
50 eV and 1 keV. The influence of an external magnetic field 
was then taken into account by determining the resulting 
distribution of the fractional number of molecules having a 
certain orientation. This distribution was used together with 
the aforementioned data set in order to calculate the mean 
values of the DCS in presence of a magnetic field. 
Results: The values of the mean DCS in presence of magnetic 
field were compared to those with zero field. For 1.5 T, only 
minor discrepancies of about 7 x10-8 and 1x10-9 were found 
for elastic scattering and ionisation respectively. 
Conclusions: The results show no significant influence of the 
magnetic field in the range corresponding to MRI-linac 
devices. Consequently, no changes are necessary in the DCS 
data used by Monte Carlo simulation codes for dose 
calculation. 
[1] The EMRP is jointly funded by the EMRP participating 
countries within EURAMET and the European Union. 
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Purpose/Objective: In many cases treatments to the chest 
wall require complete skin coverage, specifically for patients 
with stage pT4 disease or with infiltrating carcinoma. Helical 
Tomotherapy makes it possible to create treatment plans 
that deliver higher doses to the skin in comparison with other 
treatments (3D and fixed-gantry IMRT treatments), even 
without the use of bolus. This work aimed to evaluate, by 
means of Gafchromic EBT3 films (ISP® Corporation), the skin 
dose given to patients with chest wall carcinoma undergoing 
adjuvant tomohelical treatments with and without bolus and 
also using a virtual bolus, which makes it possible to 
compensate a potential under-coverage due to breathing 
motion. 
Materials and Methods: The study was conducted on a 
Tomotherapy Hi-Art® System (Accuray®, Sunnyvale, CA). 
First of all, standard treatment plans (2Gy/fr) were 
optimized using the TomoTherapy TPS (Version 4.2.2) and 
delivered to an anthropomorphic phantom (RANDO® 
Phantom), which had previously been scanned (slice 
